Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Malaria Treatment Industry?

The size of the malaria treatment market has consistently expanded over the past few years. The market’s growth is projected to increase from $1.55 billion in 2024 to $1.61 billion in 2025, with a compound annual growth rate (CAGR) of 3.9%. The surge observed in the past was a result of the identification of efficient medications, efforts to control mosquito populations, global health campaigns, extensive scientific research, and enhancements in health infrastructure.

There is an anticipation for robust expansion in the malaria treatment market in the upcoming years, with a projected increase to “$2.03 billion by 2029, coupled with a compound annual growth rate (CAGR) of 6.0%. The anticipated growth during this forecasted period may be due to factors such as drug resistance monitoring, the influence of climate change, advances in precision medicine and genomics, healthcare funding reforms, and the incorporation of digital health solutions. The major trends to watch for during this period include enhanced epidemiological surveillance, the inclusion of alternative medicine, the development of a malaria vaccine, data-informed treatment plans, and initiatives focused on education and training.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11939&type=smp

#Which Factors Are Currently Driving The Growth Of The Malaria Treatment Market?

The growing number of malaria cases is predicted to drive the growth of the malaria treatment market. Malaria, a potentially fatal disease transmitted through the bite of a mosquito carrying the Plasmodium parasite, brings about periodic fever and symptoms similar to the flu. Contributing factors to this trend are poverty, inadequate healthcare access, fluctuations in climate conditions, absence of measures to control malaria, and drug resistance. Effective management and complete eradication of the infection caused by the Plasmodium parasite is possible through malaria treatment. For instance, a report about malaria all over the world in 2023 released by the World Health Organization, an intergovernmental organization based in Switzerland, stated that global malaria cases amounted to 249 million in 2022, marking an increase by five million from the previous year. Consequently, the rising prevalence of malaria is fueling the growth of the malaria treatment market.

The malaria treatment market covered in this report is segmented –

1) By Treatment: Prescription Medications, Vaccines, Diagnostic Tests, Other Treatments

2) By Route Of Administration: Oral, Parenteral, Intravenous

3) By Distribution Channel: Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

4) By End User: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Prescription Medications: Antimalarial Drugs, Prophylactic Medications

2) By Vaccines: RTS,S Or AS01, Other Experimental Vaccines

3) By Diagnostic Tests: Rapid Diagnostic Tests, Microscopy-Based Tests, Polymerase Chain Reaction (PCR) Tests

4) By Other Treatments: Supportive Care, Herbal Remedies, Vector Control Measures

What Trends Are Currently Influencing Growth In The Malaria Treatment Market?

Significant entities active in the malaria treatment market are advancing technologies like the VERV Program to improve efficiency and effectiveness of diagnosing and managing malaria, with a goal to decrease the disease impact in endemic areas. The VERV Program, an initiative by the EPA, promotes the creation of innovative mosquito control products to counter diseases like malaria, by proposing fast-tracked review vouchers for registration. For example, in December 2023, the Vector Expedited Review Voucher (VERV) Program was introduced by the Environmental Protection Agency (EPA), a US government-based agency. The VERV Program aims to offer financial rewards to businesses that invent new pesticides specifically designed for mosquito strains resistant to conventional insecticides. The program plans to hasten the registration process for eligible products, thus accelerating their market entry.

Who Are The Main Participants Shaping The Malaria Treatment Market Landscape?

Major companies operating in the malaria treatment market include Pfizer Inc., Merck & Co., Johnson & Johnson, Roche Holding AG, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca Plc, GlaxoSmithKline PLC., Takeda Pharmaceutical Company Limited, Sumitomo Chemical Co. Ltd., Viatris Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Serum Institute of India, Cipla Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., Zydus Lifesciences Limited, Ipca Laboratories Ltd., Chongqing Holley Pharmaceutical Co. Ltd., Zydus Lifesciences Ltd., Medicines Sans Frontières, Strides Pharma Science Limited, Swiss Tropical and Public Health Institute (Swiss TPH), AdvaCare Pharma USA LLC, Medicines for Malaria Venture (MMV), VLP Therapeutics LLC, Actiza Pharmaceutical Private Limited

https://www.thebusinessresearchcompany.com/report/malaria-treatment-global-market-report

Which Region Currently Holds The Largest Share In The Malaria Treatment Market?

Middle East and Africa was the largest region in the malaria treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malaria treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11939&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model